Targeting histone demethylases as a potential cancer therapy (Review)

Wenfei Diao(Guangdong Academy of Medical Sciences), Songhui Xu(Nanchang University), Jiabin Zheng(Guangdong Academy of Medical Sciences), Junjiang Wang(Guangdong Academy of Medical Sciences), Yong Li(Guangdong Academy of Medical Sciences)
International Journal of Oncology
July 7, 2022
10.3892/ijo.2022.5393
Cited by 29

Related Papers

Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells
|Proceedings of the National Academy of Sciences|2018|107
Global identification of miR‐373‐regulated genes in breast cancer by quantitative proteomics
|PROTEOMICS|2011|88
<scp>ACK1</scp> promotes gastric cancer epithelial–mesenchymal transition and metastasis through <scp>AKT–POU2F1–ECD</scp> signalling
|The Journal of Pathology|2015|80
p300-Mediated Acetylation of Histone Demethylase JMJD1A Prevents Its Degradation by Ubiquitin Ligase STUB1 and Enhances Its Activity in Prostate Cancer
|Cancer Research|2020|66
Down‐regulation of <scp>TRPS1</scp> stimulates epithelial–mesenchymal transition and metastasis through repression of <i><scp>FOXA1</scp></i>
|The Journal of Pathology|2016|65